ALLMedicine™ Radical Prostatectomy Center

May 14th, 2022 - The purpose of this study was to immunohistochemically validate the primary tumor PSMA expression in prostate cancer (PCa) patients imaged with [68Ga]Ga-PSMA PET/CT prior to surgery, with special consideration of PET-negative cases. The study incl...

May 14th, 2022 - The mainstays of the management of clinically localized prostate cancer have historically rested upon active surveillance, radiation therapy, or radical prostatectomy. Although both radiation and surgical treatment of localized prostate cancer can...

May 14th, 2022 - Objectives; To compare the short-term and 1-yr follow-up functional outcomes of modified anatomical structures preserving and retzius-repairing robot-assisted radical prostatectomy (APR-RARP) compared with retzius-sparing (RS) RARP. Methods; 80 co...

May 13th, 2022 - Background: Most men diagnosed with prostate cancer will present with intermediate or high-risk disease, and many develop castrate resistant prostate cancer (CRPC) as curative strategies are often unsuccessful Treatment options typically involve r...

May 13th, 2022 - The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Nov 14th, 2020 - Prostate bed (PB) irradiation is considered the standard postoperative treatment after radical prostatectomy (RP) for tumors with high-risk features or persistent prostate-specific antigen, or for salvage treatment in case of biological relapse. F...

Jun 27th, 2020 - Controversies and uncertainty persist in prostate cancer grading. To update grading recommendations. Critical review of the literature along with pathology and clinician surveys. Percent Gleason pattern 4 (%GP4) is as follows: (1) report %GP4 in n...

May 5th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

Mar 28th, 2017 - Purpose To jointly update the Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer to account for new evidence. Methods An Update Panel conducted a targeted systematic literature review and identified more recent random...

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

May 13th, 2022 - Background: Most men diagnosed with prostate cancer will present with intermediate or high-risk disease, and many develop castrate resistant prostate cancer (CRPC) as curative strategies are often unsuccessful Treatment options typically involve r...

May 13th, 2022 - The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

May 13th, 2022 - Background: Androgen deprivation therapy (ADT) and surveillance are treatment options for prostate cancer patients with biochemical progression after localized therapy (i.e., biochemically recurrent [BCR] prostate cancer). The primary goal in thes...

May 9th, 2022 - In this prospective randomized study, patients with early biochemical recurrence after radical prostatectomy and with PSMA-PET positive unilateral pelvic metastatic lesions are assessed as to whether unilateral and bilateral salvage lymph node dis...

May 6th, 2022 - The primary objective of this trial is to determine if adjuvant apalutamide in prostate cancer patients at high risk of developing subsequent metastatic disease results in prolonged biochemically recurrence-free survival after radical prostatectom...

Feb 18th, 2022 - The utilization of 18F-rhPSMA-7.3 imaging displayed a clinically meaningful correct detection rate (CDR), meeting the prespecified threshhold of assessing suspected biochemical recurrence in prostate cancer, according to findings from the phase 3 ...

Feb 15th, 2022 - Key clinical point: In patients with prostate cancer, salvage radiotherapy (SRT) for biochemical recurrence after radical prostatectomy is associated with improved survival in the long term. Major finding: The median follow up was 95.

Jan 14th, 2022 - Among men with clinically localized prostate cancer who continued active surveillance (AS) after biopsy progression, delaying surgery did not significantly reduce recurrence-free survival (RFS) rates or increase the risk of adverse pathology, rese...

Dec 29th, 2021 - Radical prostatectomy after confirmation of cancer via two advanced imaging techniques without biopsy is feasible, according to a retrospective study of 25 patients who refused biopsies. "Results of our case series may trigger the discussion about...

Dec 18th, 2021 - Key clinical point: More than 9% of men with prostate cancer undergoing radical prostatectomy report a bad urinary incontinence score. Only approximately 9% of these men receive subsequent incontinence surgery.